The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
about
A20 inhibits tumor necrosis factor (TNF) alpha-induced apoptosis by disrupting recruitment of TRADD and RIP to the TNF receptor 1 complex in Jurkat T cells.TRAF-interacting protein (TRIP): a novel component of the tumor necrosis factor receptor (TNFR)- and CD30-TRAF signaling complexes that inhibits TRAF2-mediated NF-kappaB activationTAFII105 mediates activation of anti-apoptotic genes by NF-kappaBRaf kinase inhibitor protein interacts with NF-kappaB-inducing kinase and TAK1 and inhibits NF-kappaB activationNF-kappaB induces expression of the Bcl-2 homologue A1/Bfl-1 to preferentially suppress chemotherapy-induced apoptosisThe tumor necrosis factor-inducible zinc finger protein A20 interacts with TRAF1/TRAF2 and inhibits NF-kappaB activationFailure to regulate TNF-induced NF-kappaB and cell death responses in A20-deficient miceLife and death of lymphocytes: a role in immunesenescencePoly-ubiquitination in TNFR1-mediated necroptosisImmunoregulatory Effects Triggered by Lactic Acid Bacteria Exopolysaccharides: New Insights into Molecular Interactions with Host CellsEquine herpesvirus protein E10 induces membrane recruitment and phosphorylation of its cellular homologue, bcl-10The zinc finger protein A20 targets TRAF2 to the lysosomes for degradationNur77 as a survival factor in tumor necrosis factor signalingTargeting A20 decreases glioma stem cell survival and tumor growth.Dynamic cross-talk analysis among TNF-R, TLR-4 and IL-1R signalings in TNFalpha-induced inflammatory responsesCa2+ influx via TRPC channels induces NF-kappaB-dependent A20 expression to prevent thrombin-induced apoptosis in endothelial cells.Control of cell cycle entry and apoptosis in B lymphocytes infected by Epstein-Barr virus.Hepatocyte growth factor preferentially activates the anti-inflammatory arm of NF-κB signaling to induce A20 and protect renal proximal tubular epithelial cells from inflammation.Recent advances in the genetics of systemic lupus erythematosus.Enterocyte-specific A20 deficiency sensitizes to tumor necrosis factor-induced toxicity and experimental colitis.Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethalityThe ubiquitin-modifying enzyme A20 restricts ubiquitination of the kinase RIPK3 and protects cells from necroptosisCell fusion to study nuclear-cytoplasmic interactions in endothelial cell apoptosisCytoplasmic sequestration of p53 in cytomegalovirus-infected human endothelial cells.Simultaneous Overexpression of Functional Human HO-1, E5NT and ENTPD1 Protects Murine Fibroblasts against TNF-α-Induced Injury In VitroThe Epstein-Barr virus latent membrane protein 1 induces expression of the epidermal growth factor receptor.The adenovirus E3-14.7K protein and the E3-10.4K/14.5K complex of proteins, which independently inhibit tumor necrosis factor (TNF)-induced apoptosis, also independently inhibit TNF-induced release of arachidonic acid.Epstein-Barr virus latent membrane protein 1 blocks p53-mediated apoptosis through the induction of the A20 gene.Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.Overexpression of MALT1-A20-NF-κB in adult B-cell acute lymphoblastic leukemiaThe Immunomodulatory Small Molecule Imiquimod Induces Apoptosis in Devil Facial Tumour Cell LinesSuppression of steady-state, but not stimulus-induced NF-kappaB activity inhibits alphavirus-induced apoptosisActivation and homologous desensitization of human endothelial cells by CD40 ligand, tumor necrosis factor, and interleukin 1.A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets.The role of A20 in the pathogenesis of lymphocytic malignancy.A20: linking a complex regulator of ubiquitylation to immunity and human diseaseNuclear c-Myc plays an important role in the cytotoxicity of tumor necrosis factor alpha in tumor cellsA20/TNFAIP3 inhibits NF-κB activation induced by the Kaposi's sarcoma-associated herpesvirus vFLIP oncoprotein.IRG1 induced by heme oxygenase-1/carbon monoxide inhibits LPS-mediated sepsis and pro-inflammatory cytokine production.
P2860
Q24304048-FF6CBCBD-BE58-4B2D-9406-0EB2A5D8E9FEQ24313308-9E21F826-A26E-4EB7-B1EB-3338BE66DB71Q24533311-96828E23-375E-4C21-8C98-1859522803C7Q24548297-F292948C-4D25-493A-BE66-2F42E846CF78Q24554454-72854C79-90B5-482F-90D4-268B75D43979Q24610637-F205799E-CC61-450A-A459-5B0912C9946EQ24616207-FF13850A-6503-4056-82D9-9AD75EED527FQ24816962-726A1A19-81C8-4A20-9225-7FB63626D7C8Q26749315-1054047F-0400-4CBE-AE80-00F20A6C2C7BQ28078715-86EB5227-997D-47B6-80F1-76CA101D7CDAQ28118973-3004AA21-B5BE-40A6-94CF-A137BCDD8D21Q28509686-CAE4FCCA-1E53-4FBC-8286-031F61B39F3FQ28511631-B571A3C4-EB0F-4B4C-8141-8AFFFF885B2DQ33534629-376DACAE-4293-4F9B-8FA2-2B95ED1F9E1DQ33585802-7A49323D-B663-4FFC-B05F-6A6BEAAB57F4Q33727637-891B4629-BEEA-4E64-B236-659783A6686EQ33813615-2A4179D5-E218-441A-AA69-B34A4870B5E5Q33913784-B7CE2528-253E-492F-809D-AAF616CC3CE0Q33964547-3BDD181B-ED4C-4772-A53E-69D78404A4A4Q33979901-115F35A6-1C56-4DDD-BE51-55C0634A4DC3Q34071248-E85925A9-49BA-41A9-B9CD-A99AAFD5BCB1Q35064315-DF1AD757-C0E3-41B8-B6A6-E5CB70046171Q35630131-F76FF98B-7BA6-4347-A51B-6A47377E96D6Q35782346-0944D6BA-4A46-4430-B20C-7DA09756A560Q35782519-49F020E1-6C6F-4306-82CD-A78B594A7C9DQ35826059-FCB9209A-1A56-450D-973D-CB08D31FFDB6Q35841701-F19BAC28-9149-45C3-B438-8331AB100999Q35865485-DBC1F700-37A4-421D-878E-AE28C3ABA34AQ35873657-404B628D-FDB4-46D8-BE95-8DB7E4120473Q35875444-3C0B8AAF-5530-4C95-B6F8-616F0A47AC3EQ35888867-D9E9BF83-11A9-4770-A7C2-ABF916A36D32Q36218717-9CA7837F-A70F-4627-8F8A-48A16BE5BAF8Q36256156-13F09458-104B-4396-A60A-11C1BCEF411BQ36367016-33BA7893-5415-4ADA-81FE-1D56CFFF4808Q36375424-5E1ADC71-D130-4A69-AF63-3EDA6564C6D0Q36455774-1EC537CD-DCF1-4338-B22B-0A3CC1FA057EQ36638963-4E4A834A-D9B9-4577-8CCF-A1BB3FD6AF46Q36664480-215267A8-E358-4290-8B77-9C0DAE271599Q36673788-381FF357-1634-448C-A89E-6BF9C9C7558DQ36674414-64046B85-F862-40C2-8A6D-57F53B8FDF42
P2860
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
description
1992 nî lūn-bûn
@nan
1992 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@ast
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@en
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@nl
type
label
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@ast
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@en
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@nl
prefLabel
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@ast
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@en
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity.
@nl
P2093
P1476
The A20 zinc finger protein protects cells from tumor necrosis factor cytotoxicity
@en
P2093
P304
12424-12427
P407
P577
1992-06-01T00:00:00Z